Search Medical Condition
Please enter condition
Please choose location from dropdown

XinJiang, China Clinical Trials

A listing of XinJiang, China clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality

Chronic stable coronary artery disease (SCAD) is a general term for all kinds of coronary artery disease (CAD) which includes patients with chronic stable angina, oldmyocardial infarctions and also stable condition after revascularization (i.e percutaneous coronary intervention PCI, coronary artery bypass graft CABG). According to 2012 American Heart Association/American College ...

Phase N/A

0.0 miles

Learn More »

Evaluation of Tamoxifen's Efficacy for ER/PR Negative ER-beta Positive Operable Breast Cancer Patients

The current study is a multicentre, randomized,double-blind, prospective clinical trial stratified patients by the HER2 status of their cancer (negative or positive) which is sponsored by the researchers. The trial is designed to evaluate the effectiveness of tamoxifen as adjuvant therapy for ER(ER-)/PR negative, ER- positive operable breast cancer patients. ...

Phase

0.0 miles

Learn More »

A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast

In this study, the investigators conducted a hospital-based retrospective clinical study, recruiting female advanced breast cancer patients from 14 tertiary hospitals at 7 classic geographic regions, to study the clinical epidemiologic characteristics of advanced breast cancer and the current standard of clinical diagnosis and treatment in order to provide references ...

Phase N/A

0.0 miles

Learn More »

Improve SCA Bridge Study

To determine how many patients are referred for sudden cardiac death (SCD) risk stratification and management, indicated for implantable cardioverter defibrillator (ICD), or cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such devices within 12 months of experiencing an MI.

Phase N/A

0.0 miles

Learn More »